Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.20.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]    
Revenues, net $ 2,163,719 $ 320,383
Cost of goods sold 1,236,051 79,126
Gross profit 927,668 241,257
Operating expenses:    
General and administration 7,641,234 4,792,867
Sales and marketing 1,223,767 5,403,901
Research and development 3,586,553 5,416,425
Total operating expense 12,451,554 15,613,193
Operating loss (11,523,886) (15,371,936)
Other income (expense)    
Other income 20,209 12,691
Interest income 251 1,863
Interest expense (1,936,847) (2,929,369)
Change in fair value of derivative liability (37,607)
Impairment of deferred offering costs and financing costs associated with canceled financing efforts (919,950)
Loss on disposal of fixed assets (183,431)
Total other income (expense) (1,953,994) (4,018,196)
Loss before provision for income taxes (13,477,880) (19,390,132)
Provision for income taxes
Net loss $ (13,477,880) $ (19,390,132)
Net loss per share - basic and diluted (in Dollars per share) $ (0.66) $ (1.10)
Weighted average number of common shares outstanding, basic and diluted (in Shares) 20,428,490 17,610,925